Clinical Trials in Seattle

Showing 6701-6720 of 9,312 trials

Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis

NCT02576457

The purpose of this study is to determine whether BMS-936559 is safe and has the desired pharmacologic activity in patients who have severe sepsis.

Severe SepsisSeptic Shock

Bristol-Myers Squibb35 participantsStarted Dec 2015

Sacramento, California, United States • Denver, Colorado, United States • Gainesville, Florida, United States +10 more locations

COMPLETEDPhase 1< 1 mile

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer

NCT01727076

This phase I trial studies the side effects and best dose of recombinant interleukin-15 in treating patients with melanoma, kidney cancer, non-small cell lung cancer, or head and neck cancer that has spread to other places in the body and usually cannot be cured or controlled with treatment. Recombinant interleukin-(IL)15 is a biological product, a protein, made naturally in the body and when made in the laboratory may help stimulate the immune system in different ways and stop tumor cells from growing.

Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck CarcinomaRecurrent Non-Small Cell Lung Carcinoma+11 more

National Cancer Institute (NCI)20 participantsStarted Feb 2013

Palo Alto, California, United States • Bethesda, Maryland, United States • Minneapolis, Minnesota, United States +2 more locations

Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis

Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck Cancer

Find Trials by Condition in Seattle

FlaxFx, A Research Study of the Effects of Flaxseed Lignans on Colon Health

THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder

Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors

GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease

Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder

A Study to Determine if Antibiotics Prevent Infection in the Pancreas of Patients Where Part of the Pancreas Has Died

Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia

A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).

Study Evaluating HKI-272 Administered to Healthy Subjects

A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza

A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis

Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma

A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation